Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Dr. Jaap Goudsmit is Global Head of the Janssen Prevention Center, part of the Janssen Pharmaceutical Companies of Johnson & Johnson. Prior to the launch of the Janssen Prevention Center, Professor Goudsmit was Chief Executive Officer and Chief Scientific Officer of the Crucell Vaccine Institute (CVI), a Janssen discovery group established in 2011 following Johnson & Johnson’s acquisition of vaccine company Crucell earlier that year. Before the creation of CVI, Professor Goudsmit was Crucell’s Chief Scientific Officer and a member of its management board. Professor Goudsmit is special advisor to Trevor Mundel, President of Global Health at the Bill & Melinda Gates Foundation, and chairs an external advisory board that works with the foundation’s HIV program. He was founding chair of the Scientific Advisory Committee of the International AIDS Initiative (IAVI) and co-founder of EuroVac, the European Union vaccine effort against HIV. He has authored/coauthored more than 500 scientific publications, and has written several non-fiction books providing fascinating insights into diseases and their prevention.
Disease prevention, HIV, Pediatrics Infectious Diseases, Vaccines
Roos A, Roozendaal R, Riahi SD, Vreugdenhil J, Vaneman J, Dekking L, Koldijk M, Goudsmit J and RadoševiÃÂ K
Research Article: J Vaccines Vaccin